secwatch / observer
8-K filed May 12, 2026, 5:21 PM ET ticker INFU CIK 0001337013
other material confidence high sentiment neutral materiality 0.15

InfuSystem stockholders approve equity plan amendment raising share reserve to 7M

InfuSystem Holdings, Inc

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

InfuSystem Holdings, Inc shareholders approved Advisory vote on executive compensation at the 2026-05-11 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-05-11
Exact text from the filing
Proposal No. 2: The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's proxy statement as follows: For Against Abstain Broker Non-Votes 11,915,842 1,071,346 83,491 3,728,285
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

InfuSystem Holdings, Inc shareholders approved Amendment to the 2021 Equity Plan to increase authorized shares at the 2026-05-11 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2026-05-11
Exact text from the filing
Proposal No. 3: The Company's stockholders approved the amendment to the Company's 2021 Equity Plan to increase the number of authorized shares under the 2021 Equity Plan as follows: For Against Abstain Broker Non-Votes 10,770,778 2,199,707 100,194 3,728,285
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

InfuSystem Holdings, Inc shareholders approved Ratification of Grant Thornton LLP as independent registered public accounting firm at the 2026-05-11 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-11
Exact text from the filing
Proposal No. 4: The Company's stockholders ratified the appointment of Grant Thornton LLP as the Company's registered independent accounting firm for the fiscal year ending December 31, 2026 as follows: For Against Abstain Broker Non-Votes 16,604,725 613 193,626 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

InfuSystem Holdings, Inc shareholders approved Election of Directors at the 2026-05-11 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-05-11
Exact text from the filing
Proposal No. 1: The Company's Board Nominees For Against Abstain Broker Non-Votes Kenneth D. Eichenbaum, MD, MSE 11,921,195 827,929 321,555 3,728,285 Paul A. Gendron 12,614,275 276,474 179,930 3,728,285 Ronald Hundzinksi 12,368,646 611,294 90,739 3,728,285 Beverly A. Huss 11,890,777 847,243 332,659 3,728,285 Carrie Lachance 12,920,694 65,053 84,932 3,728,285 Scott Shuda 11,914,592 834,532 321,555 3,728,285 Dr. John J. Sviokla 12,227,773 521,341 321,565 3,728,285 All seven of the Company's Board nominees (Drs Eichenbaum and Sviokla, Messrs. Gendron, Hundzkinski, and Shuda and Mses. Huss and Lachance) were elected to the Board.
View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

InfuSystem Holdings, Inc filing history →

Source: SEC EDGAR
accession 0001628280-26-034217
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.